BG Medicine Announces Publication of First Study on Use of Galectin-3 in Selection of Drug Therapy in Heart Failure
May 14, 2012 08:15 ET
|
BG Medicine, Inc.
WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine, Inc. Announces Availability of Galectin-3 Diagnostic Testing Through Mayo Medical Laboratories
May 14, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., May 14, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that...
BG Medicine Announces First Quarter 2012 Financial Results Release Date and Conference Call Information
May 09, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., May 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the first quarter of fiscal year 2012 will be released before market open...
BG Medicine, Inc. Announces Important New Galectin-3 Findings Presented at American College of Cardiology's (ACC) 61st Annual Scientific Session & Expo
March 26, 2012 07:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 26, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today the...
BG Medicine, Inc. Announces Schedule of Events Related to Galectin-3 and Heart Failure at American College of Cardiology's 61st Annual Scientific Session & Expo
March 13, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today a...
BG Medicine Announces Fourth Quarter and Full Year Fiscal 2011 Results
March 08, 2012 07:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 8, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced its consolidated results of operations for the fourth quarter and the full year ended December 31,...
BG Medicine Announces Fourth Quarter and Fiscal Year 2011 Financial Results Release Date and Conference Call Information
March 02, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., March 2, 2012 (GLOBE NEWSWIRE) -- BG Medicine Inc. (Nasdaq:BGMD) today announced that its financial results for the fourth quarter and fiscal year 2011 will be released before market...
BG Medicine, Inc. to Present at Upcoming Cowen Health Care Conference
February 29, 2012 08:30 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Feb. 29, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...
BG Medicine Announces Positive Pivotal Validation Study Results for CardioSCORE, a New Diagnostic Blood Test to Identify Individuals at High Risk for Near-term Major Cardiovascular Events
February 13, 2012 08:00 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, today announced...
BG Medicine, Inc. Secures $15 Million Loan Facility From GE Capital and Comerica
February 13, 2012 07:50 ET
|
BG Medicine, Inc.
WALTHAM, Mass., Feb. 13, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel, biomarker-based diagnostics, announced today...